NCT04943276View on ClinicalTrials.gov

A Novel Noninvasive Thermoregulatory Device for Postural Tachycardia Syndrome

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 27, 2022

Primary Completion Date

November 3, 2023

Study Completion Date

November 3, 2023

Conditions
Postural Tachycardia Syndrome
Interventions
DEVICE

Embr Device

The Embr thermal device will be worn at all times from study start to the study endpoint.

Trial Locations (1)

94305

Stanford Neuroscience Health Center, Stanford

All Listed Sponsors
collaborator

Embr Labs, Inc.

INDUSTRY

lead

Stanford University

OTHER